Treace to Present at Bank of America Health Care Conference

Rhea-AI Summary

Treace Medical Concepts, Inc. will be presenting at the Bank of America Health Care Conference on May 15, 2024. The company's CEO and CFO will participate in a fireside chat to discuss their innovative surgical procedures for bunions and midfoot deformities. Investors can access the webcast on the company's investor relations website.

Wednesday, May 15, 2024, at 2:20 pm Pacific Time

PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty^® and Adductoplasty^® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Bank of America Health Care Conference on Wednesday, May 15, 2024, beginning at approximately 2:20 pm PT.

A live webcast and replay of the fireside chat will be available on the Company’s investor relations website at https://investors.treace.com/.

Internet Posting of Information

Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.

About Treace Medical Concepts

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty^® 3D Bunion Correction^® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion patients, Treace has introduced its Adductoplasty^® Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate™ Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty^® and Adductoplasty^® procedures, as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com.

To learn more about Treace, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Contacts:

Treace Medical Concepts
Julie Dewey, IRC
Chief Communications & Investor Relations Officer
jddewey@treace.com | 209-613-6945

 

When will Treace Medical Concepts, Inc. present at the Bank of America Health Care Conference?

Treace Medical Concepts, Inc. will present at the Bank of America Health Care Conference on May 15, 2024.

What are the flagship procedures of Treace Medical Concepts, Inc.?

Treace Medical Concepts, Inc. specializes in Lapiplasty® and Adductoplasty® Procedures for the surgical treatment of bunions and midfoot deformities.

Who will participate in the fireside chat at the conference?

John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in the fireside chat at the Bank of America Health Care Conference.

Where can investors access the webcast of the fireside chat?

Investors can access the webcast of the fireside chat on Treace Medical Concepts, Inc.'s investor relations website at https://investors.treace.com/.